Antiaging Properties of the Klotho Protein
Cells · 2026
DOI: 10.3390/cells15060507 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, 2026. Verfasst von Gérald J Prud'homme und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON M5S 1A8, Canada. Hauptthemen laut MEDLINE: Aging, Glucuronidase. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 200 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Juvenile Diabetes Research Foundation International, Diabetes Canada, National Science Foundation of China.
Abstract (Originalsprache)
Mice genetically deficient in α-Klotho (henceforth Klotho) display accelerated aging. The mechanisms are only partially understood. Here, we examine how these relate to the 12 hallmarks of aging consisting of chronic inflammation (inflammaging), as well as damaging changes to the genome (DNA damage), telomeres, epigenetic regulation, proteostasis, nutrient sensing, mitochondria, stem cells, intercellular communication, macroautophagy, microbiome and cell replication (senescence). Inflammation aggravates the other hallmarks. We report that Klotho counters the majority of these hallmarks. It ameliorates mitochondrial function and reduces reactive oxygen species (ROS), telomere attrition and cellular senescence. It protects against inflammation by inhibiting NF-κB and the NLRP3 inflammasome. This applies to inflammaging, several chronic inflammatory diseases, atherosclerosis, diabetes, and Alzheimer’s disease. Klotho also counters some aging factors outside of these hallmarks. Low Klotho (often due to kidney disease) produces hyperphosphatemia, which injures cells (especially endothelial cells) and promotes aging. Another key action of Klotho is the mitigation of fibrosis in major organs (kidneys, heart, lungs and other), mainly through the inhibition of TGF-β and Wnt. Klotho also protects against muscle atrophy (sarcopenia)—a common feature of aging—and exhibits anti-cancer activity. We describe several factors that increase Klotho, and are potentially amenable to clinical therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON M5S 1A8, Canada.
- Department of Laboratory Medicine, Keenan Research Centre for Biomedical Science, Unity Health Toronto, Toronto, ON M5B 1W8, Canada.
- Department of Endocrinology and Metabolism, Huashan Hospital, Shanghai Medical School, Fudan University, Shanghai 200433, China.
- Shanghai Innogen Pharmaceutical Co., Ltd., Shanghai 200135, China.
Förderung
- Juvenile Diabetes Research Foundation International
- Diabetes Canada
- National Science Foundation of China
- St. Michael's Hospital Foundation, Toronto, Canada
- Keenan Research Centre for Biomedical Science, Toronto, Canada
Zitieren
APA
Prud'homme, G. J., & Wang, Q. (2026). Antiaging Properties of the Klotho Protein. Cells. https://doi.org/10.3390/cells15060507
Vancouver
Prud'homme GJ, Wang Q. Antiaging Properties of the Klotho Protein. Cells. 2026. doi:10.3390/cells15060507
BibTeX
@article{Prudhomme2026,
author = {Prud'homme, Gérald J and Wang, Qinghua},
title = {Antiaging Properties of the Klotho Protein},
journal = {Cells},
year = {2026},
doi = {10.3390/cells15060507}
}
EUVIMED